Wolverine Trading, LLC Lannett CO Inc Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$5.75 - $7.13 $29,681 - $36,805	-5,162 Reduced 33.95%	10,043 $64,000
Q2 2020 Aug 13, 2020	BUY	$6.43 - $9.86 $1,575 - $2,415	245 Added 1.64%	15,205 $108,000
Q1 2020 May 11, 2020	BUY	$6.36 - $10.05 $10,417 - $16,461	1,638 Added 12.3%	14,960 $113,000
Q4 2019 Feb 12, 2020	SELL	$8.49 - $12.81 $19,620 - $29,603	-2,311 Reduced 14.78%	13,322 $113,000
Q4 2018 Feb 14, 2019	SELL	$3.43 - $6.19 $116,983 - $211,116	-34,106 Reduced 68.57%	15,633 $80,000
Q3 2018 Nov 14, 2018	BUY	$4.75 - $14.5 $164,654 - $502,628	34,664 Added 229.94%	49,739 $236,000
Q4 2017 Feb 14, 2018	BUY	$19.9 - $29.25 $299,992 - $440,943	15,075	15,075 $350,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.